Expression of AR, 5&agr;R1 and 5&agr;R2 in bladder urothelial carcinoma and relationship to clinicopathological factors

[1]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[2]  T. Tammela,et al.  Immunodetection of androgen receptor in human urinary bladder cancer , 1997, Histopathology.

[3]  S. Imaoka,et al.  Androgen regulation of CYP4B1 responsible for mutagenic activation of bladder carcinogens in the rat bladder: detection of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction. , 2001, Cancer letters.

[4]  Takashi Suzuki,et al.  Estrogen-Related Receptor α in Human Breast Carcinoma as a Potent Prognostic Factor , 2004, Cancer Research.

[5]  E. Messing,et al.  Gender, racial and age differences in bladder cancer incidence and mortality. , 2004, Urologic oncology.

[6]  S. Boorjian,et al.  Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. , 2004, Urology.

[7]  Takashi Suzuki,et al.  In situ androgen producing enzymes in human prostate cancer. , 2005, Endocrine-related cancer.

[8]  D. Michaud,et al.  Hormonal and reproductive factors and the risk of bladder cancer in women. , 2006, American journal of epidemiology.

[9]  Takashi Suzuki,et al.  Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. , 2007, Endocrine-related cancer.

[10]  Takashi Suzuki,et al.  Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. , 2007, Cancer research.

[11]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[12]  Aimee M. Johnson,et al.  Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1 , 2008, BMC urology.

[13]  D. Tindall,et al.  Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. , 2008, Endocrine-related cancer.

[14]  S. Xia,et al.  Androgen receptor is a potential therapeutic target for bladder cancer. , 2010, Urology.

[15]  A. Evans,et al.  Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study , 2011, BJU international.

[16]  Jorge Yao,et al.  1056 ANDROGEN UP-REGULATES THE EXPRESSION OF EGFR AND ERBB2 IN BLADDER CANCER CELLS , 2011 .

[17]  M. Oktay,et al.  Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. , 2011, Urologic oncology.

[18]  Yi Li,et al.  Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor , 2012, International journal of oncology.

[19]  E. Messing,et al.  Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder , 2012, BJU international.

[20]  L. Kiemeney,et al.  Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.

[21]  Chawnshang Chang,et al.  Androgen receptor signals regulate UDP‐glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen‐induced bladder carcinogenesis , 2013, Molecular carcinogenesis.

[22]  Yifeng Jing,et al.  Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition. , 2014, Cancer letters.

[23]  A. Sangoi,et al.  Androgen receptor immunohistochemistry in genitourinary neoplasms , 2014, International Urology and Nephrology.

[24]  Sung Woo Park,et al.  Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder Cancer , 2014, Yonsei medical journal.

[25]  Yi Li,et al.  GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens. , 2014, American journal of cancer research.

[26]  Kotaro Suzuki,et al.  Androgen deprivation therapy prevents bladder cancer recurrence , 2014, Oncotarget.

[27]  A. Mehrsai,et al.  Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study. , 2014, Urology journal.

[28]  G. Netto,et al.  ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression , 2015, Oncotarget.

[29]  H. Honda,et al.  Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy. , 2015 .

[30]  I. Thompson,et al.  Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. , 2016, European urology.

[31]  M. Shiota,et al.  Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5&agr;‐Reductase Inhibitor , 2017, The Journal of urology.

[32]  A. Hood,et al.  Gender , 2019, Textile History.